VencoreÂ has partnered withÂ Havas HealthÂ to market data analytics technology that aims to help pharmaceutical companiesÂ identify peopleÂ withÂ rare diseases.
Mac Curtis, Vencore CEO and an inductee into Executive Mosaic‘s Wash100 for 2016, said Friday the partnershipÂ will allow the companyÂ “to expand itsÂ reach and make a life-changing, and in some cases life-saving, impact on patients who suffer fromÂ ailments that have gone undiagnosed for years.”
Vencore has built a patient finder technology that employs analytical and machine learning algorithms to examine patient data as well as toÂ integrate electronic health records, claims and genomics data.
Donna Murphy, CEO of Havas Health, said the alliance also seeks to help manufacturers link their drug products to candidate patients with the technology.
Vencore has worked with pharmaceutical and biotechnology firms over the last two years to incorporate the company’s analytics platformÂ into 12 clinical trials and pilot programs.